Down-regulation of lncRNA-NEAT1 alleviated the non-alcoholic fatty liver disease via mTOR/S6K1 signaling pathway
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Down-regulation of lncRNA-NEAT1 alleviated the non-alcoholic fatty liver disease via mTOR/S6K1 signaling pathway
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 119, Issue 2, Pages 1567-1574
Publisher
Wiley
Online
2017-08-04
DOI
10.1002/jcb.26317
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long Non-Coding RNA Profiling in a Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight into Pathogenesis
- (2017) Yi Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Long Noncoding RNA NEAT1 Exerts Antihantaviral Effects by Acting as Positive Feedback for RIG-I Signaling
- (2017) Hongwei Ma et al. JOURNAL OF VIROLOGY
- Protective effects of various ratios of DHA/EPA supplementation on high-fat diet-induced liver damage in mice
- (2017) Tingting Shang et al. Lipids in Health and Disease
- Long noncoding RNA NEAT1 promotes cell proliferation and invasion by regulating hnRNP A2 expression in hepatocellular carcinoma cells
- (2017) Yuanyi Mang et al. OncoTargets and Therapy
- MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease
- (2017) Xiao-Chen Wang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Long noncoding RNAs: Re-writing dogmas of RNA processing and stability
- (2016) Jeremy E. Wilusz Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- ERK-dependent mTOR pathway is involved in berberine-induced autophagy in hepatic steatosis
- (2016) Qin He et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Lipid-lowering, hepatoprotective, and atheroprotective effects of the mixture Hong-Qu and gypenosides in hyperlipidemia with NAFLD rats
- (2016) San-Hu Gou et al. Journal of the Chinese Medical Association
- Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice
- (2016) Chun-Mei Wang et al. Lipids in Health and Disease
- Activation of mTORC1 disrupted LDL receptor pathway: A potential new mechanism for the progression of non-alcoholic fatty liver disease
- (2015) Jing Liu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles
- (2015) Xinlu Yuan et al. Journal of Translational Medicine
- Long Non-Coding RNA NEAT1 Associates with SRp40 to Temporally Regulate PPARγ2 Splicing during Adipogenesis in 3T3-L1 Cells
- (2014) Denise Cooper et al. Genes
- Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK–mTOR–SREBP signaling pathway
- (2013) Hai Yan Quan et al. BIOCHEMICAL PHARMACOLOGY
- Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes
- (2013) Andreas L. Birkenfeld et al. HEPATOLOGY
- Glycogen synthase kinase (GSK)-3 and mammalian target of rapamycin complex 1 (mTORC1) cooperate to regulate protein S6 kinase 1 (S6K1)
- (2012) Sejeong Shin et al. CELL CYCLE
- Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
- (2010) Dina G. Tiniakos et al. Annual Review of Pathology-Mechanisms of Disease
- SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth
- (2008) Thomas Porstmann et al. Cell Metabolism
- The role of mTOR in the adaptation and failure of β-cells in type 2 diabetes
- (2008) G. Leibowitz et al. DIABETES OBESITY & METABOLISM
- Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
- (2008) G MUSSO et al. PROGRESS IN LIPID RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started